Acorah Software Products - Accounts Production 16.4.675 false true false true No description of principal activity 16 March 2024 31 March 2025 31 March 2025 SC803284 Mrs Sare Arastoo iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC803284 2024-03-15 SC803284 2025-03-31 SC803284 2024-03-16 2025-03-31 SC803284 frs-core:CurrentFinancialInstruments 2025-03-31 SC803284 frs-bus:PrivateLimitedCompanyLtd 2024-03-16 2025-03-31 SC803284 frs-bus:FilletedAccounts 2024-03-16 2025-03-31 SC803284 frs-bus:Micro-entities 2024-03-16 2025-03-31 SC803284 frs-bus:AuditExempt-NoAccountantsReport 2024-03-16 2025-03-31 SC803284 frs-bus:Director1 2024-03-16 2025-03-31
Registered number: SC803284
313 Pharmaceuticals Ltd
Financial Statements
For the Period 16 March 2024 to 31 March 2025
Khokhar McAdam Ltd
Chartered Accountants
1 Eagle Street
Glasgow
G4 9XA
Balance Sheet
Registered number: SC803284
31 March 2025
£
Current assets 437
Creditors: Amounts Falling Due Within One Year (1,872 )
NET CURRENT LIABILITIES (1,435 )
TOTAL ASSETS LESS CURRENT LIABILITIES (1,435 )
Accruals and deferred income (435 )
NET LIABILITIES (1,870 )
CAPITAL AND RESERVES (1,870 )

Notes

1. General Information
313 Pharmaceuticals Ltd is a private company, limited by shares, incorporated in Scotland, registered number SC803284 . The registered office is Craighall Business Park, 1 Eagle Street, Glasgow, G4 9XA.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Sare Arastoo
Director
17 June 2025